Clinical Trial Update: Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing first-line bendamustine plus rituximab, followed by maintenance rituximab, in patients with follicular lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Bendamustine (Bendamustine)
• Rituximab (rituximab)

Snippet

Sponsor: National Research Center for Hematology, Russia | Conditions: Follicular Lymphoma | Phase 3 | Status: UNKNOWN